Elicera Therapeutics
About:
Elicera Therapeutics is a clinical stage immuno-oncology company.
Website: https://www.elicera.com/
Top Investors: European Innovation Council, Vinnova
Description:
Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments.
Total Funding Amount:
$3.24M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Göteborg, Vastra Gotaland, Sweden
Founded Date:
2013-01-01
Contact Email:
info(AT)elicera.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2022-06-02
IPO Status:
Public
Industries:
© 2025 bioDAO.ai